These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16605285)

  • 1. Productivity costs in health-state valuations : does explicit instruction matter?
    Krol M; Brouwer W; Sendi P
    Pharmacoeconomics; 2006; 24(4):401-14. PubMed ID: 16605285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises.
    Krol M; Sendi P; Brouwer W
    Value Health; 2009; 12(1):172-80. PubMed ID: 18647262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the EQ-5D reflect lost earnings?
    Tilling C; Krol M; Tsuchiya A; Brazier J; Exel Jv; Brouwer W
    Pharmacoeconomics; 2012 Jan; 30(1):47-61. PubMed ID: 22066754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incorporation of income and leisure in health state valuations when the measure is silent: an empirical inquiry into the sound of silence.
    Brouwer WB; Grootenboer S; Sendi P
    Med Decis Making; 2009; 29(4):503-12. PubMed ID: 19509120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations.
    Sendi P; Brouwer WB
    Health Econ; 2005 Jun; 14(6):643-7. PubMed ID: 15678519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should Cost-Effectiveness Analysis Include the Cost of Consumption Activities? AN Empirical Investigation.
    Adarkwah CC; Sadoghi A; Gandjour A
    Health Econ; 2016 Feb; 25(2):249-56. PubMed ID: 25684073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In or out? Income losses in health state valuations: a review.
    Tilling C; Krol M; Tsuchiya A; Brazier J; Brouwer W
    Value Health; 2010; 13(2):298-305. PubMed ID: 19804433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do individuals consider expected income when valuing health states?
    Davidson T; Levin LA
    Int J Technol Assess Health Care; 2008; 24(4):488-94. PubMed ID: 18828945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure.
    Johnson JA; Ohinmaa A; Murti B; Sintonen H; Coons SJ
    Med Decis Making; 2000; 20(3):281-9. PubMed ID: 10929850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient versus general population health state valuations: a case study of non-specific low back pain.
    van Dongen JM; van denBerg B; Bekkering GE; van Tulder MW; Ostelo RWJG
    Qual Life Res; 2017 Jun; 26(6):1627-1633. PubMed ID: 28155048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation in schistosomiasis: valuation of health states preferences. A research note.
    Kirigia JM
    Health Econ; 1998 Sep; 7(6):551-6. PubMed ID: 9809712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].
    Lamers LM; Stalmeier PF; McDonnell J; Krabbe PF; van Busschbach JJ
    Ned Tijdschr Geneeskd; 2005 Jul; 149(28):1574-8. PubMed ID: 16038162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
    Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ
    Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuing Health States in Russia: A First Feasibility Study.
    Khabibullina A; Gerry CJ
    Value Health Reg Issues; 2019 Sep; 19():75-80. PubMed ID: 31181452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.